In this initiative, a platform is being developed to provide health plans with access to continually updated data, interventions, toolkits and resources they need to optimize medication interventions for their patient populations, in different contexts.

Initiative Director(s). Gina Moore, PharmD, MBA, University of Colorado, Anschutz

In this initiative, research, action, funding and wellness stakeholders representing key US community pharmacy stakeholders will rapidly identify, prioritize, fund and support implementation of a set of innovations for transforming the role of community pharmacies from 2022 - 2031.

Initiative Director: TBD

In this initiative, research, action, funding and wellness stakeholders representing key US medications ecosystem stakeholders, will join with leading stakeholders in the US personal data management and equity investment space, to rapidly identify, prioritize, fund and support a set of TIEs for a new global marketplace for personally-owned, globally shared health and life data.

Initiative Director: Judah Thornewill, PhD, University of Louisville. Includes University of South Carolina, and University of Louisville and others (to be invited).

In this initiative, a platform is being developed to help organizations measure and improve equity related to medications access and use across the US.

Initiative Directors: Michael Hogue, Loma Linda University; Donney Johns, Nova ScriptsCentral

In this initiative, research, action, funding and wellness stakeholders representing key US medications ecosystem stakeholders, will work to develop TIEs to enable unified measures needed guide research and action to optimize medication use in the US and beyond from 2022 - 2031. The study will include focus on: Non-Optimized Medication Therapy Surveillance System; Wellbeing outcome measures (CDC OHMs, Healthy Days); Healthcare STAR ratings (Quintuple Aim).

Initiative Director: TBD

Many workforce challenges face physicians, pharmacists, technicians, nurses, dentists, caregivers and others involved in supporting patient use of medications and vaccines. This initiative will focus on transformational research and action to strengthen the workforce for the 21st century.

We are currently exploring how to put together this initiative. One idea is to bring together leading associations of schools and colleges representing pharmacists, physicians, public health, nursing, dentistry and business and health administration to co-create strategies for addressing this challenge.

Initiative Director: TBD

This goal of this initiative is to enhance the RAPID Alliance Strategic Framework 2022 - 2031 by cross-walking it with strategic plans from national associations, government agencies, and leading organizations interested in optimizing use of medications, vaccines and related therapies from 2022-2031. A systematic analysis of source and target strategies will be conducted to identify strategic gaps and opportunities. Partners in this initiative will benefit by gaining insights into ways to update their plans to align with the overall framework. The RAPID Alliance will benefit by strengthening alignment with existing strategies in the field. Consulting firms are sought to partner with RAPID Alliance on this initiative.

This initiative will work on a fast-track method for designing, testing and scaling a national multi-year, multi-site "hub/spoke" practice/payment model using clinical-decision-support enhanced pharmacist services. It will build on successful models demonstrated as part of the CMMI MTM+ studies 2018-2021.

Initiative Director: TBD

This initiative will seek to identify transformational evidence-based strategies for attributing services to pharmacists, physicians, nurses and others, in order to support measurement and drive value at national and state levels.

Initiative Directors: Anna Dopp, PharmD, Eric Mayorka, PharmD, American Society of Health-System Pharmacists (ASHP).

This initiative will focus on strategies and research priorities for strengthening the role of US pharmacists to serve in a provider capacity, in limited ways, working in collaboration with (and under the guidance) of physicians and other clinicians.

Initiative Director: TBD

This initiative is focused on optimizing medication use through patient engagement and shared value based incentives

Initiative Director: Anandi V. Law, Professor & Associate Dean for Assessment, Western University of Health Sciences; others (open)

Lack of ability to access and share comprehensive medications related data across care settings is a critical factor limiting ability to support personalized medication use services for people. Many new technologies, standards and methods are emerging with potential to address this challenge. This innovation space will work to identify and disseminate new innovations and best practices in this area.

This initiative will look at a novel method for sharing clinical trial information with patients through a unified platform.

Initiative Director: Eric Hoffman(Binghamton University), Robert Esterhay(University of Louisville)

This initiative will evaluate methods for co-creating shared services that can allow multiple-universities to access shared research data to support collaborative research

Initiative Director: TBD

This initiative is bringing together a select group of Emeritus Deans, Chairs, Researchers, CEOs and Senior Leaders to provide "points of light" (guidance, support, mentorship, perspective and connections) for other participants. They will also help raise funds to support initiative planning and implementation across the US.

Initiative Director. Michelle Fritsch, PharmD, BCGP (Professor, and Chair Emeritus, Notre Dame of Maryland School of Pharmacy, 2008 - 2015)

Problem. This initiative is focused on co-creating and Implementing an international framework for accelerating innovation in the personalized manufacturing space for the pharmacy sector.

Initiative Director: Alex C. Lin, PhD, University of Cincinnati

This initiative is focusing on how to optimize use of all vaccines, including COVID-19, Influenza, HPV, and Shingles for US populations from 2022 - 2031.

Initiative Director: Karen MacKinnon, Medical College of Wisconsin

Approach: This initiative is evaluating strategies and research priorities to increase influenza vaccine uptake for US populations through US pharmacies and other channels.

Initiative Director: Judah Thornewill, PhD University of Louisville; Karen MacKinnon, Medical College of Wisconsin

This initiative is evaluating models, strategies and research priorities for optimizing medications use for rural populations.

Initiative Director: Brittany Riley, PharmD, Marshall University School of Pharmacy.

This Initiative is focusing on evaluating models, strategies and research priorities for reducing incidence of substance use disorders, include opioid use, in the US.

Initiative Director: John Roll, PhD, Washington State University.

Approach: This initiative will focus on accelerating adoption of comprehensive medication management (CMM) services at local, state and national scales. It will seek to draw on implementation science, and existing collaborations, to drive advances in this area.

Initiative Director: TBD

Approach: This Initiative will focus on evaluating models, strategies and research priorities for strengthening maternal and child health related to medications, vaccines, tests and other related services.

Initiative Director: TBD

This initiative will focus on optimizing treatment therapies and building adherence behaviors for effective management of diabetes at both state and national levels.

Initiative Director: Kelsie Snow, PharmD, Husson University, Maine

Initiative Director: TBD

In this initiative, scholars and leaders will work together to evaluate unmet needs and barriers to pharmacy care for immigrant populations in the US with a goal of creating and implementing transformational strategies for these US immigrant populations

Initiative Director. Van Hellerslia, PharmD, Temple University

This initiative will evaluate models, strategies and research priorities for addressing antimicrobial resistance challenges at national and state levels.

Initiative Director: Jerika Lam, Chapman University

This initiative will evaluate models, strategies and research priorities for optimizing medications use for veterans.

Initiative Director: TBD

This Initiative will focus on co-creating strategies and research priorities for optimizing medications in palliative care and hospice

Initiative Director: Marshall University( Gayle A. Brazeau, Ph.D. , Brittany Riley, Pharm. D.), University of Louisville(Judah Thornewill, Ph.D )

Improving patient care through targeted molecular analysis of cancer

Initiative Director: University of Cincinnati, Georg Weber, PhD